It’s easy to assume that a medical degree signals trustworthy intent. But when you’re footing the bill for a pharmacy benefit plan, blind trust is expensive. Some prescribers don’t just treat patients. They also treat themselves to a slice of your pharmacy spend.
When Prescribing Becomes a Profit Center
Let’s get this out of the way: most physicians act with integrity. But “most” doesn’t cover your risk. Physician-driven FWA often hides in plain sight and can take many forms:
- Unnecessary brand prescribing: Choosing high-cost brand-name drugs when a clinically equivalent generic is available.
- Off-label prescribing of specialty medications: Using drugs outside of FDA-approved indications, often encouraged by aggressive pharma reps or financial arrangements with specialty pharmacies.
- Script mills: Prescribers linked to telehealth or compounding pharmacy operations that churn out high-cost, low-value scripts for the same handful of drugs.
- Financial entanglements: Kickbacks, referral fees, or ownership stakes in pharmacies create a direct conflict of interest that drives wasteful prescribing.
- Therapy changes based on DTC influence: Some prescribers switch patients to expensive medications simply because the patient saw a TV commercial or social media ad, even when the current therapy, or a lower-cost alternative, is clinically sound and cost-effective.
And all of it is being billed to your plan.
Credentials Don’t Equal Clinical Prudence
The white coat carries weight. But that credibility can be weaponized. A prescription from a licensed MD looks authoritative to patients and even PBMs. Yet if no one is looking behind the script pad, plan sponsors can be left paying for treatments that lack clinical justification or economic sense.
It’s not just about medical integrity. It is about financial discipline. That is something plan sponsors can’t afford to assume is baked into every prescription.
A Fiduciary Lens: Auditing Prescribers Like You Audit Claims
Your duty as a plan sponsor isn’t just to trust. It is to verify. That means:
- Prescriber-level audits: Identify outlier physicians whose prescribing patterns deviate from clinical norms.
- Utilization controls: Flag suspect behaviors like excessive use of certain drug classes or unusual prescribing volumes.
- Tighter prior authorization policies: Especially for high-cost brands or specialty meds, ensure there’s a legitimate medical need before plan dollars are spent.
These controls aren’t punitive. They are protective of your plan assets, your fiduciary responsibilities, and your members’ health.
Look Past the Lab Coat
Fraud, waste, and abuse don’t always look like fraud. Sometimes they look like “care.” But when prescribing decisions are driven by economics or marketing instead of evidence, the plan and the patient lose.
Don’t just audit claims. Audit intent.
If you’re not scrutinizing prescribers, you’re not protecting your plan. Reach out to TransparentRx to learn how prescriber-level oversight can stop financial leakage before it starts.
Elevate your expertise in pharmacy benefits management with the Certified Pharmacy Benefits Specialist® (CPBS) program, sponsored by the UNC-Chapel Hill Eshelman School of Pharmacy. Whether you’re an HR leader, finance executive, consultant, or pharmacist, this certification provides the in-depth knowledge and strategic insight needed to manage pharmacy benefits with confidence and cost efficiency. Gain up to twenty continuing education credits, enhance your career prospects, and help your organization take control of pharmacy spend. Register today to join a growing network of professionals shaping the future of pharmacy benefits management. Learn more at the Pharmacy Benefit Institute of America.
